Corpus Intelligence IC Memo — ADVOCATE NORTHSIDE HEALTH SYSTEM 2026-04-26 03:50 UTC
IC Memo — ADVOCATE NORTHSIDE HEALTH SYSTEM
Investment Committee Memorandum | IL | 233 beds | Grade C | EBITDA uplift $52.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVOCATE NORTHSIDE HEALTH SYSTEM

CCN 140182 | COOK, IL | 233 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVOCATE NORTHSIDE HEALTH SYSTEM is a 233-bed suburban community hospital in COOK, IL with $713.2M in net patient revenue and a 18.5% operating margin. The hospital serves a payer mix of 20.7% Medicare, 5.0% Medicaid, and 74.3% commercial.

Thesis: Platform Growth. Our ML models identify $52.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.5% to 25.9% (+736bps).

Net Revenue HCRIS$713.2M
Current EBITDA COMPUTED$132.0M
Operating Margin COMPUTED18.5%
Occupancy HCRIS61.2%
Revenue / Bed COMPUTED$3.1M
Net-to-Gross HCRIS31.5%
Distress Probability ML43.4%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
89
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 18.5% places it above the state median. Among 89 size-comparable peers (116-466 beds), the median margin is -9.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (116-466), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVOCATE NORTHSIDE HEALTH SYST (Target)IL233$713.2M18.5%
CENTRAL DUPAGE HOSPITALIL347$1.30B16.4%
CARLE FOUNDATION HOSPITALIL433$1.22B11.8%
ANN & ROBERT H. LURIE CHILDRENIL364$1.17B-12.8%
BOARD OF TRUSTEES OF THE UNIVEIL395$1.14B-12.3%
JOHN H. STROGER JR. HOSP OF COIL429$945.3M-22.4%
SWEDISHAMERICAN HOSPITALIL324$752.0M-2.8%
SPRINGFIELD MEMORIAL HOSPITALIL389$732.9M-14.5%
NORTHWEST COMMUNITY HOSPITALIL424$687.9M-1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $52.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$15.0M+210bp18mo
Cost to Collect4.5%2.5%$14.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$14.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.7M+122bp9mo
Clean Claim Rate88.0%96.0%$456K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$15.0M
Cost to Collect
$14.3M
Denial Rate Reduction
$14.1M
A/R Days Reduction
$8.7M
Clean Claim Rate
$456K
Total EBITDA Uplift$52.5M
Current EBITDA$132.0M
+ RCM Uplift+$52.5M
Pro Forma EBITDA$184.5M
Current Margin18.5%
Pro Forma Margin25.9%
WC Released (1x)$27.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$203.0M$1.40B6.87x47.0%
Base (11x exit)10.0x11.0x$203.0M$1.60B7.89x51.1%
Bull Case9.0x11.0x$182.7M$1.84B10.07x58.7%
Bull (12x exit)9.0x12.0x$182.7M$2.06B11.28x62.4%
Bear Case11.0x10.0x$223.3M$1.07B4.78x36.7%
Bear (11x exit)11.0x11.0x$223.3M$1.25B5.58x41.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 116-466 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-20.8% / P50=-9.3% / P75=0.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.